Pre-order Enquiry
Request Free Sample
Global Insulin Delivery System Market Professional Survey Report 2019
SKU ID : QYR-14624888 | Publishing Date : 03-Sep-2019 | No. of pages : 122
There are many different types of insulin delivery devices available including syringes, pens, jet injectors, oral insulin and pumps which are detailed in the report.
Furthermore, insulin that can be inhaled and other new approached to insulin treatment are at different stages of availability and development throughout the world.
The global Insulin Delivery System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 6.5% during 2019-2025.
This report focuses on Insulin Delivery System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Delivery System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Delivery System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin Delivery System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
BD
Novo Nordisk
Sanofi
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
InsuJet
Insulet
MannKind
Owen Mumford
Roche
SHL
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Insulin Syringes
Insulin PumpS
Insulin Pens
Segment by Application
Hospitals
Home Care
Furthermore, insulin that can be inhaled and other new approached to insulin treatment are at different stages of availability and development throughout the world.
The global Insulin Delivery System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 6.5% during 2019-2025.
This report focuses on Insulin Delivery System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Delivery System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Delivery System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin Delivery System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
BD
Novo Nordisk
Sanofi
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
InsuJet
Insulet
MannKind
Owen Mumford
Roche
SHL
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Insulin Syringes
Insulin PumpS
Insulin Pens
Segment by Application
Hospitals
Home Care
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
